This Week in Health: HIV prevention drug appears promising

A recent study showed a new HIV prevention drug to protect monkeys from becoming infected with a virus similar to HIV Credit: Colourbox
A recent study showed a new HIV prevention drug to protect monkeys from becoming infected with a virus similar to HIV
Credit: Colourbox

Potential HIV prevention drug fares well in animal study

Location of study: U.S.

Study subjects: Rhesus macaque monkeys

Results: A new drug in development to prevent HIV infection showed promising results in a recent animal study. The drug at the center of the research blocks replication of the virus by inhibiting a viral enzyme from inserting DNA into chromosomes. The animal study investigated the drug’s protective effect in monkeys using a virus resembling HIV. Transmission by way of anal intercourse was simulated via intrarectal injection of the virus. “We treated the rhesus macaques with the drug then challenged the animals repeatedly with the virus to see if they’d get infected,” said Dr. Martin Markowitz, co-investigator and clinical director at the Aaron Diamond AIDS Research Center. “The treated monkeys did not get infected, while the untreated ones did.” In fact, 100 percent of the drug-treated monkeys remained virus-free.

Significance: Researchers say the data provides them with enough rationale to move forward with initial safety testing in humans. Developed by GlaxoSmithKline, the drug will soon be tested in sexually active men who are at low risk for HIV infection. Researchers hope to test the drug among high-risk individuals thereafter. The drug has the potential to prevent HIV via a shot administered every three months.

Prolonged survival for cervical cancer patients linked to new drug

Location of study: Brazil

Study subjects: 36 women with cervical cancer

Results: A new targeted therapy may potentially change the standard of care for advanced cervical cancer. In a recent study, researchers at the Brazilian National Cancer Institute tested the effectiveness of an EGFR inhibitor called erlotinib. The drug was administered to participants in combination with standard chemoradiation. Over 94 percent of the women exhibited a complete disappearance of all cancerous lesions. What’s more is that after two years, over 90 percent of the patients were still alive with 80.6 percent experiencing no disease progression.

Significance: An over expression of EGFR is strongly associated with cervical cancer tumors. Inhibiting it seems to render better results than the standard treatment (chemoradiation therapy). “More effective and better-tolerated therapies are required for the management of locally advanced disease,” said Dr. Angélica Nogueira-Rodrigues of the Brazilian National Cancer Institute. “Targeted therapies may be added to the standard treatment if randomized trials confirm the current promising results.”

Yoga improves quality of life for breast cancer patients, study finds

Location of study: U.S.

Study subjects: 191 women with stage zero to three breast cancer

Results: A recent study found that a regular yoga routine that included controlled breathing, meditation and relaxation techniques was linked to improved quality of life for women with breast cancer. Researchers divided the subjects into three groups with all participants continuing with their regular radiotherapy. One group participated in supplemental yoga and another added simple stretching exercises. The last group did not participate in any supplemental exercises. “What was apparent from the findings was that yoga resulted in improved aspects of quality of life, as well as improved stress hormone regulation,” said Dr. Lorenzo Cohen, director of the Integrative Medicine Program at MD Anderson Cancer Center.

Significance: The research, which is part of an overarching effort from MD Anderson Cancer Center to better understand mind-body cancer interventions, found these effects to last up to six months after completing radiotherapy and the last yoga session. Women in the yoga group were also more likely to find meaning in their cancer experience.

Allergies equally prevalent throughout U.S.

Location of study: U.S.

Study subjects: Approximately 10,000 Americans in the National Health and Nutrition Examination Survey from 2005-2006

Results: Despite the widely held belief that certain regions are more likely to trigger allergic responses, a comprehensive new study has found that allergy prevalence is relatively the same throughout different U.S. regions. The only exception, according to researchers from the National Institutes of Health, is in children five and younger. “People who are prone to develop allergies tend to become allergic to whatever is in their environment,” said Dr. Paivi Salo, an epidemiologist with the National Institute of Environmental Health Sciences. In other words, it’s what triggers an allergic reaction that varies throughout different regions. Outdoor allergies were more common in the West, while indoor allergies were more prevalent in the South. Sensitization to food allergies was highest in the South, as were sensitivities to cockroaches and dust mites.

Significance: The study represents the largest look at allergy prevalence from childhood through old age. The only participants to show a regional response to allergens were children aged one to five living in the South. This response was observed across Texas to Florida and as far north as West Virginia.

Content provided by ZipTrials, a trusted source for the most up-to-date medical news and trending health stories.



News
Entertainment
Sports
Lifestyle
National

Dr. Dre is king of hip hop with…

With $620 million in estimated pre-tax earnings, veteran rapper and record producer Dr. Dre topped Forbes list as the highest paid hip hop artist, ousting Sean "Diddy" Combs from the…

News

Bin Laden son-in-law sentenced to life in U.S.…

A seemingly unrepentant Suleiman Abu Ghaith, a son-in-law of Osama bin Laden, was sentenced to life in prison on Tuesday in New York following his conviction on terrorism charges.

Local

Inside the UN Climate Summit

First Avenue was a sea of blue suits, black Suburbans and countless officers from multiple security agencies Tuesday as the United Nations representatives met to…

National

Bloomberg: Going green will grant you longer life…

Former NYC mayor Michael Bloomberg tells Metro that cities are where fighting global warming can make a difference, and increase people’s lifespan.

Television

Craig Ferguson wants you to see his new…

Craig Ferguson thinks his new game show will become "a comedy show in which a game is played and money is won."

Television

Anthony Anderson on dealing with your 'ish'

Anthony Anderson discusses finding the humor in his "Black-ish" family.

Gossip

Photos: See who Robert Pattinson was caught holding…

Robert Pattinson has a new girlfriend.

The Word

The Word: Kris and Bruce Jenner's predictably public…

They said it wouldn't last — mostly because of that separation almost a year ago. And now, more than a year later, Kris and Bruce…

NFL

3 things that went right in Jets loss…

It wasn't the result the Jets wanted, a 27-19 loss to the Bears, but this team deserves some credit.

Sports

Here's the 8 best and worst sporting goodbyes

With Derek Jeter set to retire following the 2014 Major League Baseball season, we look back at some of the great and not-so-great sporting goodbyes.

NFL

NFL Week 4 schedule (TV, kickoff, start time)

NFL Week 4 schedule (TV, kickoff, start time)

NFL

NFL Power Rankings: Seahawks at top, Bears and…

NFL Power Rankings: Seahawks at top, Bears and Steelers rise

Home

NYC fall real estate hot list

The upcoming developments and areas everyone's buzzing about.

Style

Milan Fashion Week shows the best of Italian…

Metro rounds up the cut of the collections at Milan Fashion Week.

Tech

The 2014 Maker Faire saw robots, printers and…

Got a broken button maker? There’s a fix for that – and Tony Stanzione of the Fixers’ Collective says he can show you how.

Parenting

First look: Uniqlo's fall/winter 2014 kids collection

Get a sneak peek at Uniqlo's kids and babies fall/winter 2014 line.